Study on molecular mechanism and drug intervention of gastrointestinal neoplasms

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200066610

Enrollment

Unknown

Registered

2022-12-12

Start date

2021-06-01

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal neoplasms

Interventions

Intervention group:Non first-line treatment

Routine treatment group:First line treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Age 18-80; patients with gastrointestinal tumors

Exclusion criteria

Exclusion criteria: Death or transfer out within 24 hours after admission

Design outcomes

Primary

Measure	Time frame
Oral microbiome;biomarkers;Differential protein;Differential gene;	—

Secondary

Measure	Time frame
Inflammatory indicators;	—

Countries

China

Contacts

Public ContactFangqin Xue

Fujian Provincial Hospital

13799322969@163.com13799322969

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026